Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

ACSL4 -Associated Lipid Metabolism Is a Distinct Therapeutic Vulnerability in KMT2A -Rearranged Acute Myeloid Leukemia

Silvia Schäfer, Lola Schmitz-Hübsch, Mehak Nihal Shaikh, Silke Brilloff, Elahe Rahimian, Vida Kufrin, Sandra Küchler, Maria Fedorova, Dominic Helm, Claudia R Ball, Martin Bornhäuser, Hanno Glimm, Meritxell Alberich Jorda, Marius Bill, Alexander A Wurm

Blood (2024) 144 (Supplement 1): 1563.

https://doi.org/10.1182/blood-2024-210089

Published: 2024

Journal Articles

The Differential Impact of Secondary-Type Mutations in a Multinational Cohort of 5311 Intensively Treated Acute Myeloid Leukemia Patients

Jan-Niklas Eckardt, Marius Bill, Konstanze Döhner, Christian Rausch, Klaus H Metzeler, Karsten Spiekermann, Sebastian Stasik, Tim Sauer, Sebastian Scholl, Andreas Hochhaus, Martina Crysandt, Tim H. H. Brummendorf, Utz Krug, Bernhard Wörmann, Hermann Einsele, Wolfgang Hiddemann, Dennis Görlich, Maria Cristina Sauerland, Björn Steffen, Andreas Neubauer, Andreas Burchert, Kerstin Schaefer-Eckart, Wolfgang E. Berdel, Christoph Schliemann, Stefan W. Krause, Mathias Hänel, Maher Hanoun, Martin Kaufmann, Lars Fransecky, Jan Braess, Johannes Schetelig, Jan Moritz Middeke, Lars Bullinger, Michael Heuser, Felicitas R Thol, Hubert Serve, Claudia D Baldus, Uwe Platzbecker, Carsten Mueller-Tidow, Barbora Weinbergerova, Jiri Mayer, Pierre-Yves Dumas, Sarah Bertoli, Eric Delabesse, Christian Récher, Arnaud Pigneux, Tobias Herold, Arnold Ganser, Hartmut Döhner, Martin Bornhäuser, Christian Thiede, Christoph Röllig

Blood (2024) 144 (Supplement 1): 2934.

https://doi.org/10.1182/blood-2024-201945

Published: 2024

Journal Articles

Secondary-Type Mutations Do Not Impact the Favorable Outcome of NPM1 -Mutated Acute Myeloid Leukemia Patients - Results from a Large Cohort of Intensively Treated Patients

Blood (2023) 142 (Supplement 1): 721.

https://doi.org/10.1182/blood-2023-186160

Published: 2023

Journal Articles

Prognostic Impact of Measurable Residual Clonal Hematopoiesis after Allogeneic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia

Lara Bischof, Elizabeth Gaston, Jule Ussmann, Juliane Grimm, Marius Bill, Dominic Brauer, Donata Backhaus, Lisa Herrmann, Maximilian Merz, Marco Herling, Klaus H. Metzeler, Georg-Nikolaus Franke, Vladan Vucinic, Uwe Platzbecker, Sebastian Schwind, Madlen Jentzsch

Blood (2022) 140 (Supplement 1): 7750–7751.

https://doi.org/10.1182/blood-2022-169478

Published: 2022

Journal Articles

Quantitative Impact of Mutated NPM1 MRD in Patients with AML Undergoing Allogeneic Stem Cell Transplantation

Sebastian Schwind, Lara Bischof, Marius Bill, Juliane Grimm, Jule Ussmann, Elizabeth Gaston, Donata Backhaus, Dominic Brauer, Marco Herling, Maximilian Merz, Klaus H. Metzeler, Georg-Nikolaus Franke, Vladan Vucinic, Uwe Platzbecker, Madlen Jentzsch

Blood (2022) 140 (Supplement 1): 3412–3413.

https://doi.org/10.1182/blood-2022-163365

Published: 2022

Journal Articles

Differential Impact of Prognostically Significant Gene Mutations in Acute Myeloid Leukemia (AML) Patients (Pts) Older Than 70 Years (y) Treated with Cytarabine-Based Induction Therapy

Marius Bill, MD PhD, Jessica Kohlschmidt, PhD, Krzysztof Mrózek, MDPhD, Deedra Nicolet, MS, Christopher J. Walker, PhD, Dimitrios Papaioannou, MD, James S. Blachly, MD, Shelley Orwick, BS, Eunice S. Wang, MD, Jonathan E. Kolitz, MD, Bayard L. Powell, MD, Andrew J Carroll, PhD, Ramiro Garzon, MD, Richard M. Stone, MD, John C. Byrd, MD, Clara D. Bloomfield, MD, Ann-Kathrin Eisfeld, MD

Blood (2020) 136 (Supplement 1): 40–41.

https://doi.org/10.1182/blood-2020-141663

Published: 2020

Journal Articles

Clinical Relevance of Morphologic and Molecular Complete Remission in AML Patients Undergoing Reduced Intensity or Non-Myeloablative Conditioning

Madlen Jentzsch, MD, Dominic Brauer, Juliane Grimm, MD, Marius Bill, MD PhD, Donata Backhaus, MD, Julia Schulz, Dietger Niederweiser, MD, Uwe Platzbecker, Sebastian Schwind, MD

Blood (2020) 136 (Supplement 1): 29.

https://doi.org/10.1182/blood-2020-134102

Published: 2020

Journal Articles

CircPCMTD1 : A Protein-Coding Circular RNA That Regulates DNA Synthesis in Leukemic Myeloblasts

Dimitrios Papaioannou, MD, Remi Buisson, Andreas Petri, PhD, Allison Walker, Marius Bill, MD PhD, Felice Pepe, PhD, Deedra Nicolet, MS, Lauren A Woodward, Krzysztof Mrózek, MD PhD, Malith Karunasiri, Gregory K. Behbehani, MD PhD, Emanuele Cocucci, PhD, Guramrit Singh, PhD, Sakari Kauppinen, PhD, Adrienne M. Dorrance, PhD, Clara D. Bloomfield, MD, Ramiro Garzon, MD

Blood (2019) 134 (Supplement_1): 640.

https://doi.org/10.1182/blood-2019-126223

Published: 2019

Journal Articles

The Prognostic Impact of the Diagnostic CD34+/CD38- Cell Burden and Expression of the Stem Cell Marker GPR56 after Stem Cell Transplantation Depends on the AML Origin

Madlen Jentzsch, MD, Marius Bill, MD PhD, Juliane Grimm, MD, Dominic Brauer, MD, Julia Schulz, Karoline Goldmann, Dietger Niederwieser, MD, Uwe Platzbecker, Sebastian Schwind, MD

Blood (2019) 134 (Supplement_1): 323.

https://doi.org/10.1182/blood-2019-127544

Published: 2019

Journal Articles

Personalized Oncology in Acute Myeloid Leukemia (AML): Validation of the Prognostic Value of the Knowledge Bank Algorithm in Patients (Pts) Treated on Cancer and Leukemia Group B (CALGB)/Alliance Protocols

Marius Bill, MD PhD, Krzysztof Mrózek, MD PhD, Jessica Kohlschmidt, PhD, Deedra Nicolet, MS, Brian Giacopelli, BS, Christopher J. Walker, PhD, Dimitrios Papaioannou, MD, Ann-Kathrin Eisfeld, MD, Jonathan E. Kolitz, MD, Bayard L Powell, MD, Andrew J. Carroll, PhD, Richard M. Stone, MD, John C. Byrd, MD, Ramiro Garzon, MD, Christopher C. Oakes, PhD, Clara D. Bloomfield, MD

Blood (2019) 134 (Supplement_1): 182.

https://doi.org/10.1182/blood-2019-128623

Published: 2019

Journal Articles

Next-Generation RNA Sequencing-Based Analysis Identifies a Novel Set of Prognostic Micrornas (miRs) in Cytogenetically Normal Acute Myeloid Leukemia (CN-AML)

Dimitrios Papaioannou, MD, Deedra Nicolet, MS, Kellie J Archer, PhD, Allison Walker, Krzysztof Mrózek, MD PhD, Andrew J. Carroll, PhD, Jessica Kohlschmidt, PhD, Ann-Kathrin Eisfeld, MD, Marius Bill, MD PhD, Christopher J. Walker, PhD, Geoffrey L. Uy, MD, Bayard L Powell, MD, Jonathan E. Kolitz, MD, Richard Stone, MD, John C. Byrd, MD, Ramiro Garzon, MD, Clara D. Bloomfield, MD

Blood (2019) 134 (Supplement_1): 2694.

https://doi.org/10.1182/blood-2019-125727

Published: 2019

Journal Articles

EGFL7 Antagonizes NOTCH Signaling and Represents a Novel Therapeutic Target in Acute Myeloid Leukemia (AML)

Marius Bill, MD PhD, Aparna Pathmanathan, Malith Karunasiri, Changxian Shen, Matthew Burke, Parvathi Ranganathan, PhD, Dimitrios Papaioannou, MD, Nina C. Zitzer, DVM, Katiri Snyder, Allison LaRocco, Allison Walker, Zachary Brannan, Ansel P. Nalin, Aharon G. Freud, MD PhD, Mikhail Dikov, Xiaoli Zhang, PhD, Clara D. Bloomfield, MD, Ramiro Garzon, MD, Adrienne M. Dorrance, PhD

Blood (2019) 134 (Supplement_1): 2546.

https://doi.org/10.1182/blood-2019-131856

Published: 2019

Journal Articles

Prognostic and Biologic Significance of Transfer RNA-Derived Small RNAs (tsRNAs) Expression in Younger Adult Patients (Pts) with Cytogenetically Normal Acute Myeloid Leukemia (CN-AML)

Marius Bill, MD PhD, Dario Veneziano, PhD, Jessica Kohlschmidt, PhD, Krzysztof Mrózek, MDPhD, Giovanni Nigita, PhD, Maria G. Krantz, Deedra Nicolet, MS, Dimitrios Papaioannou, MD, Allison Walker, Zachary Brannan, Bayard L. Powell, MD, Richard M. Stone, MD, Geoffrey L. Uy, MD, Jonathan E. Kolitz, MD, Eunice S. Wang, MD, Adrienne M. Dorrance, PhD, Carlo M. Croce, MD, Ramiro Garzon, MD, Clara D. Bloomfield, MD

Blood (2018) 132 (Supplement 1): 89.

https://doi.org/10.1182/blood-2018-99-115270

Published: 2018

Journal Articles

Genome-Wide Association Study (GWAS) Identifies a Significant Acute Myeloid Leukemia (AML) Susceptibility Locus Near BICRA

Blood (2018) 132 (Supplement 1): 85.

https://doi.org/10.1182/blood-2018-99-115170

Published: 2018

Journal Articles

A 17-Gene Leukemia Stem Cell (LSC) Score in Adult Patients (Pts) with Acute Myeloid Leukemia (AML) Reveals a Distinct Mutational Landscape and Refines Current European Leukemianet (ELN) Genetic Risk Stratification

Marius Bill, MD PhD, Deedra Nicolet, MS, Ann-Kathrin Eisfeld, MD, Krzysztof Mrózek, MDPhD, Christopher J. Walker, PhD, Jessica Kohlschmidt, PhD, Dimitrios Papaioannou, MD, Jonathan E. Kolitz, MD, Bayard L. Powell, MD, John C. Byrd, MD, Ramiro Garzon, MD, Clara D. Bloomfield, MD

Blood (2018) 132 (Supplement 1): 289.

https://doi.org/10.1182/blood-2018-99-115114

Published: 2018

Journal Articles

MiR-143 Targets ERK5 in Granulopoiesis and Predicts Outcome of Patients with Acute Myeloid Leukemia

Jens-Uwe Hartmann, MSc, Daniela Bräuer-Hartmann, PhD, Miroslava Kardosova, MSc, Franziska Wilke, MSc, Alexander Arthur Wurm, PhD, Cindy Schoedel, MD, Dennis Gerloff, PhD, Christiane Katzerke, PhD, Rosanna H.E. Krakowsky, MSc, Carolina Yaeko Namasu, MSc, Marius Bill, Sebastian Schwind, MD, Carsten Müller-Tidow, Dietger W. Niederwieser, MD, Meritxell Alberich-Jorda, Gerhard Behre, MD

Blood (2017) 130 (Supplement 1): 3950.

https://doi.org/10.1182/blood.V130.Suppl_1.3950.3950

Published: 2017

Journal Articles

Mutational Landscape and Clinical Outcome Associated with Different Rearrangements Involving 11q23/ MLL in De Novo Acute Myeloid Leukemia (AML)

Marius Bill, MD PhD, Ann-Kathrin Eisfeld, MD, Krzysztof Mrózek, MDPhD, Jessica Kohlschmidt, PhD, Deedra Nicolet, MS, Christopher J. Walker, PhD, James S. Blachly, MD, Andrew Carroll, PhD, Jonathan E. Kolitz, MD, Eunice S. Wang, MD, Bayard L. Powell, MD, Richard M. Stone, MD, Albert de la Chapelle, MD PhD, John C. Byrd, MD, Clara D. Bloomfield, MD

Blood (2017) 130 (Supplement 1): 3960.

https://doi.org/10.1182/blood.V130.Suppl_1.3960.3960

Published: 2017

Journal Articles

Prognostic Impact of Clonal Hematopoiesis in Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation in Complete Remission

Juliane Grimm, Marius Bill, PhD, Madlen Jentzsch, MD, Stefanie Beinicke, MSc, Janine Häntschel, MSc, Karoline Goldmann, Julia Schulz, Michael Cross, PhD, Wolfram Pönisch, MD, Vladan Vucinic, Gerhard Behre, MD, Thoralf Lange, MD, Georg-Nikolaus Franke, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2017) 130 (Supplement 1): 406.

https://doi.org/10.1182/blood.V130.Suppl_1.406.406

Published: 2017

Journal Articles

In AML RAS pathway Mutations Confer Worse Outcome in IDH1 and IDH2 Mutated AML Patients Receiving Hematopoietic Stem Cell Transplantation

Stefanie Beinicke, MSc, Juliane Grimm, Madlen Jentzsch, MD, Marius Bill, PhD, Janine Häntschel, MSc, Karoline Goldmann, Julia Schulz, Michael Cross, PhD, Georg-Nikolaus Franke, MD, Vladan Vucinic, Wolfram Pönisch, MD, Gerhard Behre, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2017) 130 (Supplement 1): 2037.

https://doi.org/10.1182/blood.V130.Suppl_1.2037.2037

Published: 2017

Journal Articles

High Expression of the DNMT3A Embedded Pri- Mir -1301 Associates with Improved Outcome in Patients with Acute Myeloid Leukemia

Janine Häntschel, MSc, Madlen Jentzsch, MD, Juliane Grimm, Marius Bill, Stefanie Beinicke, MSc, Laura K. Schmalbrock, MD, Lynn Bonifacio, MD, Luba Schuhmann, Julia Schulz, Karoline Goldmann, Michael Cross, PhD, Georg-Nikolaus Franke, MD, Vladan Vucinic, Wolfram Pönisch, MD, Gerhard Behre, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2017) 130 (Supplement 1): 1203.

https://doi.org/10.1182/blood.V130.Suppl_1.1203.1203

Published: 2017

NARROW

ACSL4 -Associated Lipid Metabolism Is a Distinct Therapeutic Vulnerability in KMT2A -Rearranged Acute Myeloid Leukemia

The Differential Impact of Secondary-Type Mutations in a Multinational Cohort of 5311 Intensively Treated Acute Myeloid Leukemia Patients

Secondary-Type Mutations Do Not Impact the Favorable Outcome of NPM1 -Mutated Acute Myeloid Leukemia Patients - Results from a Large Cohort of Intensively Treated Patients

Prognostic Impact of Measurable Residual Clonal Hematopoiesis after Allogeneic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia

Quantitative Impact of Mutated NPM1 MRD in Patients with AML Undergoing Allogeneic Stem Cell Transplantation

Differential Impact of Prognostically Significant Gene Mutations in Acute Myeloid Leukemia (AML) Patients (Pts) Older Than 70 Years (y) Treated with Cytarabine-Based Induction Therapy

Clinical Relevance of Morphologic and Molecular Complete Remission in AML Patients Undergoing Reduced Intensity or Non-Myeloablative Conditioning

CircPCMTD1 : A Protein-Coding Circular RNA That Regulates DNA Synthesis in Leukemic Myeloblasts

The Prognostic Impact of the Diagnostic CD34+/CD38- Cell Burden and Expression of the Stem Cell Marker GPR56 after Stem Cell Transplantation Depends on the AML Origin

Personalized Oncology in Acute Myeloid Leukemia (AML): Validation of the Prognostic Value of the Knowledge Bank Algorithm in Patients (Pts) Treated on Cancer and Leukemia Group B (CALGB)/Alliance Protocols

Next-Generation RNA Sequencing-Based Analysis Identifies a Novel Set of Prognostic Micrornas (miRs) in Cytogenetically Normal Acute Myeloid Leukemia (CN-AML)

EGFL7 Antagonizes NOTCH Signaling and Represents a Novel Therapeutic Target in Acute Myeloid Leukemia (AML)

Prognostic and Biologic Significance of Transfer RNA-Derived Small RNAs (tsRNAs) Expression in Younger Adult Patients (Pts) with Cytogenetically Normal Acute Myeloid Leukemia (CN-AML)

Genome-Wide Association Study (GWAS) Identifies a Significant Acute Myeloid Leukemia (AML) Susceptibility Locus Near BICRA

A 17-Gene Leukemia Stem Cell (LSC) Score in Adult Patients (Pts) with Acute Myeloid Leukemia (AML) Reveals a Distinct Mutational Landscape and Refines Current European Leukemianet (ELN) Genetic Risk Stratification

MiR-143 Targets ERK5 in Granulopoiesis and Predicts Outcome of Patients with Acute Myeloid Leukemia

Mutational Landscape and Clinical Outcome Associated with Different Rearrangements Involving 11q23/ MLL in De Novo Acute Myeloid Leukemia (AML)

Prognostic Impact of Clonal Hematopoiesis in Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation in Complete Remission

In AML RAS pathway Mutations Confer Worse Outcome in IDH1 and IDH2 Mutated AML Patients Receiving Hematopoietic Stem Cell Transplantation

High Expression of the DNMT3A Embedded Pri- Mir -1301 Associates with Improved Outcome in Patients with Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only